A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole Tablets
Status:
Completed
Trial end date:
2020-05-09
Target enrollment:
Participant gender:
Summary
This is a single-center, open-label, randomized, two-stage, two-way crossover study
evaluating the effect of voriconazole on the PK, PD, and safety of HSK3486 in healthy
subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Sichuan Haisco Pharmaceutical Group Co., Ltd Sichuan Haisco Pharmaceutical Group Co., Ltd.
Collaborator:
The First Affiliated Hospital of Suzhou University